Agios Pharmaceuticals (AGIO) EBITDA Margin Growth (3y) (2016 - 2026)
Agios Pharmaceuticals (AGIO) EBITDA Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Agios Pharmaceuticals |
2.01 Bn |
2.01 Bn |
19.43 Mn |
108,515.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
108,515.00 |
| Dec 31, 2025 |
169,208.00 |
| Sep 30, 2025 |
168,336.00 |
| Jun 30, 2025 |
72,907.00 |
| Mar 31, 2025 |
1.09 Mn |
| Dec 31, 2023 |
-128,636.00 |
| Sep 30, 2023 |
-107,566.00 |
| Jun 30, 2023 |
-115,793.00 |
| Mar 31, 2023 |
-156,913.00 |
| Dec 31, 2022 |
-200,208.00 |
| Sep 30, 2022 |
-217,165.00 |
| Jun 30, 2022 |
-131,496.00 |
| Mar 31, 2022 |
-1.18 Mn |
| Dec 31, 2020 |
70,993.00 |
| Sep 30, 2020 |
40,770.00 |
| Jun 30, 2020 |
50,756.00 |
| Mar 31, 2020 |
58,235.00 |
| Dec 31, 2019 |
-19,827.00 |
| Sep 30, 2019 |
28,323.00 |
| Jun 30, 2019 |
36,463.00 |
